Scientist I / II (f/m/d) - In-Use studies and PPM Testing jobs in United States
cer-icon
Apply on Employer Site
company-logo

Coriolis Pharma · 3 days ago

Scientist I / II (f/m/d) - In-Use studies and PPM Testing

Coriolis Pharma is a company focused on enabling the next generation of biopharmaceutical therapies. The Scientist I / II role involves contributing to formulation development and analytical strategies, transforming scientific questions into analytical insights, and supporting client projects while ensuring compliance with GMP standards.

Pharmaceutical
check
Culture & Values
Hiring Manager
Dominik Schwemmer
linkedin

Responsibilities

Be part of project teams for client projects (e.g., liquid/lyophilization formulation development, comparability and stress testing, storage stability study) as assigned by the superior with special focus on in‑use stability studies and primary packaging material (PPM) testing:
Work as (i) 1st, 2nd project leader and/or (ii) team member for projects
Contribution/responsible for the development of work plans, testing procedures and/or amendments for customer projects
Correctly, timely and independently plan and execute formulation preparation / analytical testing / experiments
Independently perform analytical method transfer/implementation
Demonstrate solid understanding of performed analytical methods and be able to apply the knowledge to interpret the data
Perform data analysis and subsequently put data into context for data presentation and/or report
Support scientific discussion in client meeting
Appropriately act on unforeseen events
Be specialist / expert on several instruments / analytical methods / application areas (e.g., able to perform method development, interpretation of data, troubleshooting and training of new users)
Implementation of new analytical equipment / technologies and application of the methods within client projects
Support on-boarding of new team members
Liaise with superior on training needs
Act as mentor
System Owner for laboratory equipment: responsible for operator training, equipment maintenance, calibration and qualification
Ensures that GRP rules are followed and documented
Ensures general laboratory cleanliness
Other duties as assigned by superior

Qualification

Analytical method developmentHPLC/UPLC analysisIn-use stability studiesPPM comparability testingBiopharmaceutical formulationEquipment commissioningLIMSBiophysical characterizationEagerness to learnIntercultural team playerCommunication skillsTime managementProblem-solving skillsHands-on mentality

Required

University degree in pharmaceutical sciences, (bio)chemistry, biology, or a related field
Minimum 3 years of relevant experiences, e.g. employment in pharmaceutical industry / analytical laboratory (e.g. CDMO) or PhD studies
Experience with equipment commissioning, maintenance, and LIMS
Strong verbal and written communication skills
Good knowledge of English (both written and spoken)
Good time management and prioritization skills
Eagerness to learn and develop new skills
Open-minded and able to adapt strategies to changes
Strong intercultural and interdisciplinary team player
Strong problem-solving skills
Hands-on mentality: practical, solution-oriented approach with a willingness to take initiative
Candidates must be based in North Carolina (NC) or willing to relocate to NC

Preferred

Proven track record and hands-on experience in planning and executing in-use stability studies and PPM comparability testing is strongly preferred
Proficiency in HPLC/UPLC-analysis (SEC, IEX, RP, LC-CAD), CE-analysis and subvisible particle analysis (MFI, LO) highly beneficial
Additional expertise in biophysical characterization (AUC, CD, µDSC, FTIR, fluorescence), osmolality and turbidity is a plus
Knowhow in biopharmaceutical formulation development beneficial

Company

Coriolis Pharma

twittertwitter
company-logo
Coriolis Pharma is a globally operating independent service provider for research and development of biopharmaceutical drugs.

Funding

Current Stage
Growth Stage
Total Funding
unknown
Key Investors
Frontier Biosolutions
2023-10-16Corporate Round
Company data provided by crunchbase